BioQL Invest ApS: Financial statements 2019
CVR: 37755001
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
BioQL Invest ApS (CVR 37755001) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -8,812 and a net result of DKK -8,812 compared with DKK -3,125 the year before. Equity in the 2019 report amounted to DKK 6,743,588. The solvency ratio was 99.9%.
- Gross Profit
- DKK -8,812
- Profit/Loss
- DKK -8,812
- Equity
- DKK 6,743,588
- Total Assets
- DKK 6,752,338
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -9K | -9K | 6.7M | - |
| 2018 | - | -3K | -3K | 6.8M | 0 |
| 2017 | - | -72K | -73K | 6.8M | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
BioQL Invest ApS has published its annual report for 2018. Gross profit came to DKK -3,125, and the net result was DKK -3,125.
About BioQL Invest ApS
BioQL Invest ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2016. The company is registered under the industry Investering for egen regning. The management consists of Mads Bredning Rydahl and Thomas Michael Redder Laursen. The company is owned by TMRL Holding ApS and Rydahl Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -9,737 and a net result of DKK -7,949 compared with DKK -4,372 the year before. Equity in the 2025 report amounted to DKK 70,917.